Inception Return
(11/22/2007)
|
5.63 %
|
YTD Return
|
9.00 %
|
|
NAVPS
(3/31/2025)
|
$10.87
|
Change
|
($0.06) / -0.54 %
|
|
Growth of $10,000
(As of February 28, 2025)
|
MER
|
2.12 %
|
Assets ($mil)
|
$1,745.99
|
Rank (1Yr)
|
251/771
|
Std Dev (3Yr)
|
12.91 %
|
Volatility Ranking (3Yr)
|
7/10
|
RRSP Eligibility
|
Yes
|
Load
|
Front Fee Only
|
Max Front End
|
-
|
Max Back End
|
6.00 %
|
Sales Status
|
Open
|
|
Objective
The NBI SmartData International Equity Fund’s investment objective is to provide long-term capital growth. This fund invests directly, or through investments in securities of other mutual funds, in a portfolio mainly composed of equities of foreign companies located outside of North America and in American Depositary Receipts (ADRs) traded on recognized stock exchanges.
|
Fund Manager
National Bank Investments Inc.
Portfolio Manager
Len Ioffe, Goldman Sachs Asset Management LP
Osman Ali, Goldman Sachs Asset Management LP
Sub-Advisor
Data not available
|
Asset Allocation
(As of February 28, 2025)
|
Sector Allocation
(As of February 28, 2025)
|
Geographic Allocation
(As of February 28, 2025)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
Sap SE | International Equity | Technology | European Union | 2.05% |
Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 1.95% |
Novartis AG Cl N | International Equity | Healthcare | Other European | 1.78% |
Nestle SA Cl N | International Equity | Consumer Goods | Other European | 1.69% |
Cash and Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 1.66% |
Roche Holding AG - Partcptn | International Equity | Healthcare | Other European | 1.62% |
AstraZeneca PLC - ADR | International Equity | Healthcare | European Union | 1.48% |
ASML Holding NV | International Equity | Technology | European Union | 1.45% |
L'Air Liquide SA | International Equity | Basic Materials | European Union | 1.34% |
Commonwealth Bank of Australia | International Equity | Financial Services | Asia/Pacific Rim | 1.22% |
Performance Data
(As of February 28, 2025)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
2.54
|
8.47
|
6.52
|
9.00
|
16.44
|
11.14
|
9.50
|
5.21
|
Benchmark
|
1.20
|
7.16
|
5.45
|
6.99
|
14.01
|
9.73
|
9.62
|
6.64
|
Quartile Ranking
|
1
|
1
|
2
|
1
|
2
|
1
|
2
|
3
|
Calendar Return (%)
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
Fund
|
13.03
|
15.07
|
-8.20
|
9.45
|
2.69
|
12.19
|
-10.06
|
15.45
|
-2.80
|
13.37
|
Benchmark
|
11.18
|
15.74
|
-10.67
|
8.97
|
8.01
|
16.27
|
-6.81
|
18.37
|
-1.70
|
19.41
|
Quartile Ranking
|
2
|
2
|
2
|
2
|
3
|
4
|
3
|
3
|
3
|
3
|